Clinical Practice Updates in the Management Of Immune Thrombocytopenia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

1. Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis.Advances in therapy · 2021
   Pooled it
2. When GPVI Goes Rogue: Pathogenesis and Therapeutic Horizons in ITP.Expert reviews in molecular medicine · 2026
   Review
3. Cost-effectiveness of hetrombopag, eltrombopag, and avatrombopag for chronic immune thrombocytopenia in China: a cost-utility analysis.Frontiers in public health · 2026
   Article
4. The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK.Journal of market access & health policy · 2025
   Article
5. Immune Thrombocytopenia in a 94-Year-Old Woman: Challenges in Diagnosis and Management of an Uncommon Presentation in the Elderly.Cureus · 2025
   Article
6. Impact of Primary Chronic Immune Thrombocytopenia and Thrombopoietin Receptor Agonists Treatment Instructions on Daily Living: Results of a Multinational Cross-Sectional Survey.Patient preference and adherence · 2025
   Article
7. Parallel pathogens: Coexistence of chickenpox and idiopathic thrombocytopenic purpura-A case report.Clinical case reports · 2023
   Article
8. Upregulation of necroptosis markers RIPK3/MLKL and their crosstalk with autophagy-related protein Beclin-1 in primary immune thrombocytopenia.Clinical and experimental medicine · 2023
   Article
9. A Case of Vancomycin-Induced Severe Immune Thrombocytopenia.Hematology reports · 2023
   Article
10. Proteomic-Based Discovery of Predictive Biomarkers for Drug Therapy Response and Personalized Medicine in Chronic Immune Thrombocytopenia.BioMed research international · 2023
    Article
11. Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2022
    Article
12. Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection.Vaccines · 2021
    Article
13. Cost-minimization analysis comparing eltrombopag vs romiplostim for adults with chronic immune thrombocytopenia.Journal of managed care & specialty pharmacy · 2021
    Article
14. Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist.Frontiers in pharmacology · 2021
    Review
15. Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab.Cureus · 2020
    Article
16. Evaluation of treatment plan by three-period pulses of high-dose dexamethasone among patients with primary immune thrombocytopenia on platelet count response and adverse events: A randomized Clinical trial.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2020
    Article
17. CB2 Receptor Stimulation and Dexamethasone Restore the Anti-Inflammatory and Immune-Regulatory Properties of Mesenchymal Stromal Cells of Children with Immune Thrombocytopenia.International journal of molecular sciences · 2019
    Article
18. Rescue therapy for acute idiopathic thrombocytopenic purpura unresponsive to conventional treatment.BMJ case reports · 2019
    Article
19. Disrupted balance of CD4International journal of biological sciences · 2019
    Article
20. A Surgically Treated Case of Ureterovesical Amyloidosis of the Bladder in a Patient with Idiopathic Thrombocytopenia.Case reports in urology · 2018
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as